Neusignal Therapeutics

Website

Developer of small molecule drugs intended to cure brain diseases and overcome central nervous system diseases. The company engages in the research and development of therapeutic agents for dementia a...

Healthcare
Tokyo, Japan
Founded 2022
4 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$16.2M
Last Round
N/A
Investors
+8 other investors
View all 8 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Neusignal Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required